| scholarly article | Q13442814 |
| P50 | author | Dirk Arnold | Q54285507 |
| ESMO Guidelines Working Group | Q98319238 | ||
| P2093 | author name string | C Mariette | |
| A Cervantes | |||
| M Stahl | |||
| K Haustermans | |||
| P2860 | cites work | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 |
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals | Q33610263 | ||
| Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction | Q34603020 | ||
| Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial | Q34627996 | ||
| Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 | ||
| New trends for staging and therapy for localized gastroesophageal cancer: the role of PET | Q37799941 | ||
| Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer | Q37861088 | ||
| Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial | Q39374652 | ||
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. | Q39737918 | ||
| International survey on esophageal cancer: part I surgical techniques | Q40005308 | ||
| Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial | Q42646554 | ||
| Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus | Q43279914 | ||
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. | Q44022873 | ||
| Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial | Q45172897 | ||
| Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus | Q46412803 | ||
| Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers | Q46723942 | ||
| Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. | Q46923030 | ||
| Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. | Q51113785 | ||
| Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. | Q53491085 | ||
| Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 | ||
| P304 | page(s) | vi51-6 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | |
| P478 | volume | 24 Suppl 6 |
| Q99212130 | A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy |
| Q41505612 | Accuracy of endoscopic ultrasound-guided tissue acquisition in the evaluation of lymph nodes enlargement in the absence of on-site pathologist. |
| Q98466025 | Adjuvant Therapy for Esophageal Squamous Cell Carcinoma |
| Q58764952 | Anastomotic leakage after intrathoracic versus cervical oesophagogastric anastomosis for oesophageal carcinoma in Chinese population: a retrospective cohort study |
| Q42292516 | Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer |
| Q26751171 | Barrett's esophagus in 2016: From pathophysiology to treatment |
| Q91865165 | Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma |
| Q90529143 | CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway |
| Q26749536 | Cervical esophageal cancer: a gap in cancer knowledge |
| Q40872263 | Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer. |
| Q35925464 | Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study |
| Q38614101 | Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. |
| Q91791934 | Chemoradiotherapy with FOLFOX for esophageal squamous cell cancer with synchronous rectal cancer: Four case reports and a literature review |
| Q92715700 | CircRNA circFNDC3B promotes esophageal cancer progression via cell proliferation, apoptosis, and migration regulation |
| Q42361543 | Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre. |
| Q35123133 | Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. |
| Q48758201 | Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma |
| Q37074909 | Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients |
| Q47271716 | Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells |
| Q42644400 | Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial |
| Q53304850 | Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer. |
| Q33429328 | Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer |
| Q52678592 | Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer. |
| Q38611066 | Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas. |
| Q37121508 | Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort |
| Q49907705 | Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma |
| Q40085481 | Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia |
| Q89428241 | Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer |
| Q39260430 | Gastric Preconditioning in Advance of Esophageal Resection-Systematic Review and Meta-Analysis. |
| Q64065039 | Implementation of endoscopic submucosal dissection for early upper gastrointestinal tract cancer after primary experience in colorectal endoscopic submucosal dissection |
| Q38683830 | Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection. |
| Q53101919 | Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013. |
| Q49541978 | Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma |
| Q47318997 | Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial |
| Q64895487 | Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma. |
| Q24185993 | Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer |
| Q24188245 | Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer |
| Q51699761 | Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. |
| Q36222524 | Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus |
| Q34019040 | MicroRNA binding site polymorphisms as biomarkers in cancer management and research. |
| Q53691494 | MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. |
| Q89705510 | Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity |
| Q38831243 | Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management |
| Q24186005 | Non-surgical versus surgical treatment for oesophageal cancer |
| Q89060430 | Oesophageal stenting: Status quo and future challenges |
| Q38194452 | Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study |
| Q38220816 | Operable gastro-oesophageal junctional adenocarcinoma: Where to next? |
| Q49213845 | Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective |
| Q33591706 | Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer |
| Q39217503 | Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer |
| Q37499021 | Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer |
| Q40899349 | Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study |
| Q38257364 | Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues |
| Q88543029 | Staging resection of multiple primary esophageal cancer by endoscopic submucosal dissection and esophagectomy: A case report |
| Q37024180 | Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study |
| Q26753868 | Surgical Therapy of Early Carcinoma of the Esophagus |
| Q24186841 | Surgical versus non-surgical treatment for oesophageal cancer |
| Q38707804 | Surveillance of anal carcinoma after radiochemotherapy : A retrospective analysis of 80 patients. |
| Q38856978 | Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells. |
| Q37726430 | TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma |
| Q58603530 | The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma |
| Q47135563 | Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. |
| Q31133579 | Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base. |
Search more.